Book contents
- Uncommon Causes of Stroke
- Uncommon Causes of Stroke
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 Infectious Conditions
- Section 2 Inflammatory Conditions
- Section 3 Hereditary and Genetic Conditions and Malformations
- Chapter 16 Pulmonary Arteriovenous Malformations
- Chapter 17 Hereditary Hemorrhagic Telangiectasia
- Chapter 18 Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
- Chapter 19 Cerebral Autosomal-Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL)
- Chapter 20 Sickle Cell Disease and Other Hemoglobinopathies
- Chapter 21 Cerebrovascular Complications of Fabry Disease*
- Chapter 22 Marfan Syndrome
- Chapter 23 Pseudoxanthoma Elasticum
- Chapter 24 Ehlers–Danlos Syndrome
- Chapter 25 Progeria
- Chapter 26 MELAS Syndrome and Other Mitochondrial Disorders
- Chapter 27 Sturge–Weber Syndrome
- Chapter 28 Von Hippel–Lindau Disease
- Chapter 29 Familial Aneurysms
- Chapter 30 Cerebral Cavernous Malformations and Developmental Venous Anomalies
- Chapter 31 Cerebrovascular Manifestations of Neurofibromatosis
- Chapter 32 Menkes Disease
- Chapter 33 Wyburn–Mason Syndrome
- Chapter 34 Divry–van Bogaert Syndrome
- Chapter 35 Blue Rubber Bleb Syndrome
- Section 4 Vascular Conditions of the Eyes, Ears, and Brain
- Section 5 Disorders Involving Abnormal Coagulation
- Section 6 Systemic Disorders That Also Involve the Cerebrovascular System
- Section 7 Non-Inflammatory Disorders of the Arterial Wall
- Section 8 Venous Occlusive Conditions
- Section 9 Vasospastic Conditions and Other Miscellaneous Vasculopathies
- Index
- Plate Section (PDF Only)
- References
Chapter 31 - Cerebrovascular Manifestations of Neurofibromatosis
from Section 3 - Hereditary and Genetic Conditions and Malformations
Published online by Cambridge University Press: 15 June 2018
Book contents
- Uncommon Causes of Stroke
- Uncommon Causes of Stroke
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 Infectious Conditions
- Section 2 Inflammatory Conditions
- Section 3 Hereditary and Genetic Conditions and Malformations
- Chapter 16 Pulmonary Arteriovenous Malformations
- Chapter 17 Hereditary Hemorrhagic Telangiectasia
- Chapter 18 Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
- Chapter 19 Cerebral Autosomal-Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL)
- Chapter 20 Sickle Cell Disease and Other Hemoglobinopathies
- Chapter 21 Cerebrovascular Complications of Fabry Disease*
- Chapter 22 Marfan Syndrome
- Chapter 23 Pseudoxanthoma Elasticum
- Chapter 24 Ehlers–Danlos Syndrome
- Chapter 25 Progeria
- Chapter 26 MELAS Syndrome and Other Mitochondrial Disorders
- Chapter 27 Sturge–Weber Syndrome
- Chapter 28 Von Hippel–Lindau Disease
- Chapter 29 Familial Aneurysms
- Chapter 30 Cerebral Cavernous Malformations and Developmental Venous Anomalies
- Chapter 31 Cerebrovascular Manifestations of Neurofibromatosis
- Chapter 32 Menkes Disease
- Chapter 33 Wyburn–Mason Syndrome
- Chapter 34 Divry–van Bogaert Syndrome
- Chapter 35 Blue Rubber Bleb Syndrome
- Section 4 Vascular Conditions of the Eyes, Ears, and Brain
- Section 5 Disorders Involving Abnormal Coagulation
- Section 6 Systemic Disorders That Also Involve the Cerebrovascular System
- Section 7 Non-Inflammatory Disorders of the Arterial Wall
- Section 8 Venous Occlusive Conditions
- Section 9 Vasospastic Conditions and Other Miscellaneous Vasculopathies
- Index
- Plate Section (PDF Only)
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Uncommon Causes of Stroke , pp. 245 - 249Publisher: Cambridge University PressPrint publication year: 2018
References
Allanson, J. E., Hall, J. G., and Van Allen, M. I. 1985. Noonan phenotype associated with neurofibromatosis. Am J Med Genet, 21, 457–62.Google Scholar
Ars, E., Kruyer, H., Gaona, A., et al. 1998. A clinical variant of neurofibromatosis type 1: Familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene. Am J Hum Genet, 62, 834–41.Google Scholar
Barral, J. L. and Summers, C. G. 1996. Ocular ischemic syndrome in a child with moyamoya disease and neurofibromatosis. Surv Ophthalmol, 40, 500–4.Google Scholar
Bergouignan, M. and Arne, L. 1951. A propos des anévrysmes des artéres cérébrales associés à d’autres malformations. Acta Neurol et Psychiat Belgica, 51, 529–35.Google Scholar
Coleman, S. D., Williams, C. A., and Wallace, M. R. 1995. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions on NF1 gene. Nat Genet, 11, 90–2.Google Scholar
Creange, A., Zeller, J., Rostaing-Rigattieri, S., et al. 1999. Neurological complications of neurofibromatosis type 1 in adulthood. Brain, 122, 473–81.Google Scholar
Daston, M. M., Scrable, H., Nordlund, M., et al. 1992. Protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes. Neuron, 8, 415–28.Google Scholar
de Kersaint-Gilly, A., Zenthe, L., Dabouis, G., et al. 1980. Abnormalities of the intracerebral vasculature in a case of neurofibromatosis. J Neuroradiol, 7, 193–8.Google Scholar
Erickson, R. P., Woolliscroft, J., and Allen, R. J. 1980. Familial occurrence of intracranial arterial occlusive disease (moyamoya) in neurofibromatosis. Clin Genet, 18, 191–6.Google Scholar
Gebarski, S. S., Gabrielsern, T. O., Knake, J. E., and Latack, J. T. 1983. Posterior circulation intracranial arterial occlusive disease in neurofibromatosis. Am J Neuroradiol, 4, 1245–6.Google Scholar
Gilly, R., Elbaz, N., Langue, J., and Raveau, J. 1982. Sténoses artérielles cérébrales multiples et progressives, sténose d l’artère rénale et maladie de Recklinghausen. Pédiatrie, 38, 523–30.Google Scholar
Griffiths, D. F. R., Williams, G. T., and Williams, E. D. 1983. Multiple endocrine neoplasia associated with von Recklinghausen’s disease. Brit Med J, 287, 1341–3.CrossRefGoogle ScholarPubMed
Hall, J. G. 2000. Review and hypotheses: Somatic mosaicism – observations related to clinical genetics. Am J Hum Genet, 43, 355–63.Google Scholar
Hamilton, S. J. and Friedman, J. M. 2000. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet, 58, 341–4.Google Scholar
Hashemian, H. 1952. Familial fibromatosis of small intestine. Brit J Surg, 40, 346–50.Google Scholar
Hoffmann, K. T., Hosten, N., Liebig, T., Schwarz, K., and Felix, R. 1998. Giant aneurysm of the vertebral artery in neurofibromatosis type 1: Report of a case and review of the literature. Neuroradiology, 40, 245–8.CrossRefGoogle ScholarPubMed
Huson, S. M., Compston, D. A., Clark, P., and Harper, P. S. 1989. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet, 26, 704–11.Google Scholar
Koss, M., Scott, R. M., Irons, M. B., Smith, E. R., and Ullrich, N. J. 2013. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization. J Neurosurg Pediatr, 11, 417–25.Google Scholar
Latchaw, R. E., Harris, R. D., Chou, S. N., and Gold, L. H. A. 1980. Combined embolization and operation in the treatment of cervical arteriovenous malformations. Neurosurgery, 6, 131–7.Google Scholar
Lehrnbecher, T., Gassel, A. M., Rauh, V., Kirchner, T., and Huppertz, H. I. 1994. Neurofibromatosis presenting as a severe systemic vasculopathy. Eur J Pediatr, 153, 107–9.Google Scholar
Leone, R. G., Schatzki, S. C., and Wolpow, E. R. 1982. Neurofibromatosis with extensive intracranial arterial occlusive disease. Am J Neuroradiol, 3, 572–6.Google Scholar
Lesley, W. S., Thomas, M. R., and Abdulrauf, S. I. 2004. N-butylcyanoacrylate embolization of a middle meningeal artery aneurysm in a patient with neurofibromatosis type 2. Am J Neuroradiol, 25, 1414–6.Google Scholar
Levisohn, P. M., Mikhael, M. A., and Rothman, S. M. 1978. Cerebrovascular changes in neurofibromatosis. Dev Med Child Neurol, 20, 789–93.Google Scholar
Littler, M. and Morton, N. E. 1990. Segregation analysis of peripheral neurofibromatosis. J Med Genet, 27, 307–10.Google Scholar
Marchuk, D. A. and Collins, F. S. 1994. Molecular genetics of neurofibromatosis 1. In The Neurofibromatoses. A Pathogenetic and Clinical Overview, eds, Huson, S. M., and Hughes, R. A. C.. London: Chapman and Hall, pp. 23–49.Google Scholar
Negoro, M., Nakaya, T., Terashima, K., and Sugita, K. 1990. Extracranial vertebral artery aneurysm with neurofibromatosis. Endovascular treatment by detachable balloon. Neuroradiology, 31, 533–6.CrossRefGoogle ScholarPubMed
Pellock, J. M., Kleinman, P. K., McDonald, B. M., and Wixson, D. 1980. Hypertensive stroke with neurofibromatosis. Neurology, 30, 656–9.Google Scholar
Reubi, F. 1944. Les vaisseaux et les glandes endocrines dans la neurofibromatose. Z Pathu Bakt, 7, 168.Google Scholar
Riccardi, V. M. 2000. The vasculopathy of NF1 and histogenesis control genes. Clin Genet, 58, 345–7.Google Scholar
Rodriguez, H. A. and Berthrong, M. 1966. Multiple primary intracranial tumors in von Recklinghausen’s neurofibromatosis. Arch Neurol, 14, 467–75.CrossRefGoogle ScholarPubMed
Ryan, A. M., Hurley, M., Brennan, P., and Moroney, J. T. 2005. Vascular dysplasia in neurofibromatosis type 2. Neurology, 65, 163–4.Google Scholar
Salyer, W. R., and Salyer, D. C. 1974. The vascular lesions of neurofibromatosis. Angiology, 25, 510–9.CrossRefGoogle ScholarPubMed
Sasaki, J., Miura, S., Ohishi, H., and Kikuchi, K. 1995. Neurofibromatosis associated with multiple intracranial vascular lesions: Stenosis of the internal carotid artery and peripheral aneurysm of the Heubner’s artery; report of a case. No Shinkei Geka, 23, 813–7.Google ScholarPubMed
Schievink, W. I. and Piepgras, D. G. 1991. Cervical vertebral artery aneurysms and arteriovenous fistulae in neurofibromatosis type 1: Case reports. Neurosurgery, 29, 760–5.Google Scholar
Schievink, W. I., Riedinger, M., Maya, M. M. 2005. Frequency of incidental intracranial aneurysms in neurofibromatosis type 1. Am J Med Genet, 134A, 45–48.CrossRefGoogle ScholarPubMed
Scott, R. M., Smith, J. L., Robertson, R. L., et al. 2004. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg, 100(2 Suppl Pediatrics), 142–9.Google ScholarPubMed
Siddhartha, W., Chavhan, G. B., Shrivastava, M., and Limaye, U. S. 2003. Endovascular treatment for bilateral vertebral arteriovenous fistulas in neurofibromatosis 1. Australas Radiol, 47, 457–61.CrossRefGoogle ScholarPubMed
Stanley, J. C. and Fry, W. J. 1981. Pediatric renal artery occlusive disease and renovascular hypertension: Etiology, diagnosis, and operative treatment. Arch Surg, 116, 669–76.Google Scholar
Steel, T. R., Bentivoglio, P. B., and Garrick, R. 1994. Vascular neurofibromatosis affecting the internal carotid artery: A case report. Brit J Neurosurg, 8, 233–7.Google Scholar
Terry, A. R., Jordan, J. T., Schwamm, L. Plotkin, S. R. 2016. Increased risk of cerebrovascular disease among patients with neurofibromatosis type 1: Population-based approach. Stroke, 47, 60–5.Google Scholar
Tholen, A., Messmer, A. P., and Landau, K. 1998. Peripheral retinal vascular occlusive disorder in a young patient with neurofibromatosis 1. Retina, 18, 184–6.Google Scholar
Tomsick, T. A., Lukin, R. R., Chambers, A. A., and Benton, C. 1976. Neurofibromatosis and intracranial arterial occlusive disease. Neuroradiology, 11, 229–34.Google Scholar
Tong, J., Hannan, F., Zhu, Y., Bernards, A., and Zhong, Y. 2002. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. Nat Neurosci, 5, 95–6.Google Scholar
Viskochil, D. H. 1998. Gene structure and expression. In Neurofibromatosis Type 1: From Genotype to Phenotype, eds. Upadhyaya, M., and Cooper, D. N.. Oxford: Bios Scientific Publishers, pp. 39–53.Google Scholar
Xu, G., O’Connell, P., Viskochil, D. H., et al. 1990. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell, 62, 599–608.Google Scholar